Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 15.62 USD 4.34% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Progyny Inc?
Write Note

Intrinsic Value

The intrinsic value of one PGNY stock under the Base Case scenario is 38.4 USD. Compared to the current market price of 15.62 USD, Progyny Inc is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PGNY Intrinsic Value
38.4 USD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Progyny Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PGNY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PGNY?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Progyny Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Progyny Inc

Provide an overview of the primary business activities
of Progyny Inc.

What unique competitive advantages
does Progyny Inc hold over its rivals?

What risks and challenges
does Progyny Inc face in the near future?

Has there been any significant insider trading activity
in Progyny Inc recently?

Summarize the latest earnings call
of Progyny Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Progyny Inc.

Provide P/S
for Progyny Inc.

Provide P/E
for Progyny Inc.

Provide P/OCF
for Progyny Inc.

Provide P/FCFE
for Progyny Inc.

Provide P/B
for Progyny Inc.

Provide EV/S
for Progyny Inc.

Provide EV/GP
for Progyny Inc.

Provide EV/EBITDA
for Progyny Inc.

Provide EV/EBIT
for Progyny Inc.

Provide EV/OCF
for Progyny Inc.

Provide EV/FCFF
for Progyny Inc.

Provide EV/IC
for Progyny Inc.

Show me price targets
for Progyny Inc made by professional analysts.

What are the Revenue projections
for Progyny Inc?

How accurate were the past Revenue estimates
for Progyny Inc?

What are the Net Income projections
for Progyny Inc?

How accurate were the past Net Income estimates
for Progyny Inc?

What are the EPS projections
for Progyny Inc?

How accurate were the past EPS estimates
for Progyny Inc?

What are the EBIT projections
for Progyny Inc?

How accurate were the past EBIT estimates
for Progyny Inc?

Compare the revenue forecasts
for Progyny Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Progyny Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Progyny Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Progyny Inc compared to its peers.

Compare the P/E ratios
of Progyny Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Progyny Inc with its peers.

Analyze the financial leverage
of Progyny Inc compared to its main competitors.

Show all profitability ratios
for Progyny Inc.

Provide ROE
for Progyny Inc.

Provide ROA
for Progyny Inc.

Provide ROIC
for Progyny Inc.

Provide ROCE
for Progyny Inc.

Provide Gross Margin
for Progyny Inc.

Provide Operating Margin
for Progyny Inc.

Provide Net Margin
for Progyny Inc.

Provide FCF Margin
for Progyny Inc.

Show all solvency ratios
for Progyny Inc.

Provide D/E Ratio
for Progyny Inc.

Provide D/A Ratio
for Progyny Inc.

Provide Interest Coverage Ratio
for Progyny Inc.

Provide Altman Z-Score Ratio
for Progyny Inc.

Provide Quick Ratio
for Progyny Inc.

Provide Current Ratio
for Progyny Inc.

Provide Cash Ratio
for Progyny Inc.

What is the historical Revenue growth
over the last 5 years for Progyny Inc?

What is the historical Net Income growth
over the last 5 years for Progyny Inc?

What is the current Free Cash Flow
of Progyny Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Progyny Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Progyny Inc

Current Assets 546.3m
Cash & Short-Term Investments 235.7m
Receivables 280.7m
Other Current Assets 29.9m
Non-Current Assets 113.7m
PP&E 29.4m
Intangibles 17.2m
Other Non-Current Assets 67.1m
Current Liabilities 208.5m
Accounts Payable 130.5m
Accrued Liabilities 78m
Non-Current Liabilities 16.6m
Other Non-Current Liabilities 16.6m
Efficiency

Earnings Waterfall
Progyny Inc

Revenue
1.1B USD
Cost of Revenue
-891.9m USD
Gross Profit
246.8m USD
Operating Expenses
-181.4m USD
Operating Income
65.5m USD
Other Expenses
-8.2m USD
Net Income
57.3m USD

Free Cash Flow Analysis
Progyny Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PGNY Profitability Score
Profitability Due Diligence

Progyny Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive 3-Year Average ROE
56/100
Profitability
Score

Progyny Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

PGNY Solvency Score
Solvency Due Diligence

Progyny Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
75/100
Solvency
Score

Progyny Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PGNY Price Targets Summary
Progyny Inc

Wall Street analysts forecast PGNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PGNY is 19.64 USD with a low forecast of 17.17 USD and a high forecast of 23.1 USD.

Lowest
Price Target
17.17 USD
10% Upside
Average
Price Target
19.64 USD
26% Upside
Highest
Price Target
23.1 USD
48% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PGNY?

Click here to dive deeper.

Dividends

Progyny Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PGNY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PGNY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

PGNY News

Other Videos

Profile

Progyny Inc Logo
Progyny Inc

Country

United States of America

Industry

Health Care

Market Cap

1.4B USD

Dividend Yield

0%

Description

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

Contact

NEW YORK
New York City
1359 Broadway, 2Nd Floor
+12128883124.0
www.progyny.com

IPO

2019-10-25

Employees

311

Officers

Executive Chairman
Mr. David J. Schlanger
CEO & Director
Mr. Peter Anevski
President
Mr. Michael Sturmer
Chief Financial Officer
Mr. Mark S. Livingston
Executive VP, General Counsel & Secretary
Ms. Allison Swartz
Chief Technology Officer
Mr. Steven Leist
Show More
Vice President of Investor Relations
Mr. James Hart
Chief Marketing Officer
Ms. Risa Fisher
Chief Human Resources Officer
Ms. Cassandra Pratt
Chief Business Development Officer
Ms. Julie Stadlbauer
Show Less

See Also

Discover More
What is the Intrinsic Value of one PGNY stock?

The intrinsic value of one PGNY stock under the Base Case scenario is 38.4 USD.

Is PGNY stock undervalued or overvalued?

Compared to the current market price of 15.62 USD, Progyny Inc is Undervalued by 59%.

Back to Top